Tag: GLP-1 receptor agonists
GLP-1 medications reduce deaths and amputations in type 2 diabetes with peripheral artery disease
New research published in the Journal of the American Heart Association shows GLP-1 receptor agonist medications reduce deaths, amputations, and…
Diabetes and Dementia: New Evidence Reveals Bidirectional Risk and Potential Neuroprotection
Mounting evidence reveals that diabetes and dementia share bidirectional pathophysiological pathways involving impaired glucose metabolism, chronic inflammation, and vascular dysfunction.…
Submit Your Paper to GMJ
No APC until January 2027.